The Impact of Alternative Social Assistance Disbursement on Drug-related Harm (TASA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02457949 |
Recruitment Status :
Terminated
(Interim analyses produced signal of intervention efficacy for primary outcomes and weaker signal of increased exposure to violence. Therefore, DSMC recommended stopping recruitment in May 2018. Enrolled participants completed intervention by Aug 2018)
First Posted : May 29, 2015
Last Update Posted : November 17, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Drug Use | Other: Non-synchronized social assistance receipt Other: cheque divided into two equal disbursements | Not Applicable |
Coordinated monthly income assistance payments, while seeking to alleviate poverty, can also have negative and unintended impacts, particularly among people who use illicit drugs (PWUD). Observational research has identified escalations in drug-related harm coinciding with monthly assistance payments, such as overdose, treatment interruption, hospital admissions and public disorder. This project varies the timing and frequency of income assistance disbursement, and evaluates whether varying income assistance disbursement reduces drug-related harm coinciding with coordinated income assistance.
Conducted among 273 PWUD, participants will be allocated for 6 income assistance cycles to a control or one of two intervention arms. Participants in the control arm will receive payments according to the existing monthly government schedule. Participants in the intervention arm will receive their income assistance: (1) monthly on a day different from government cheque issue; or (2) semi-monthly on days different from government cheque issue. The intervention will be evaluated using qualitative and quantitative methods for its impact on drug use and related harms.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 194 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Other |
Official Title: | The Impact of Alternative Social Assistance Disbursement on Drug-Related Harm: a Randomized Control Trial |
Actual Study Start Date : | October 27, 2015 |
Actual Primary Completion Date : | January 2, 2019 |
Actual Study Completion Date : | September 30, 2019 |
Arm | Intervention/treatment |
---|---|
No Intervention: Treatment As Usual (TAU)
Receipt of social assistance on government cheque issue days for 6 income assistance cycles (approx 26 weeks).
|
|
Experimental: Staggered Arm
Receipt of social assistance once monthly on a randomly assigned day that does not fall during the week of government cheque issue (Non-synchronized social assistance receipt), for 6 income assistance cycles (approx 26 weeks).
|
Other: Non-synchronized social assistance receipt
Social assistance disbursement outside government cheque issue week
Other Name: Staggered |
Experimental: Staggered and Split Arm
Receipt of social assistance twice monthly on equally spaced randomly assigned days that do not fall during the week of government cheque issue (Non-synchronized social assistance receipt, cheque divided into two equal disbursements), for 6 income assistance cycles (approx 26 weeks).
|
Other: Non-synchronized social assistance receipt
Social assistance disbursement outside government cheque issue week
Other Name: Staggered Other: cheque divided into two equal disbursements Social assistance disbursement divided into two equal payments
Other Name: Split |
- Illicit drug use on government cheque issue days [ Time Frame: 26 weeks ]Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with government cheque issue day, compared to non-cheque issue days.
- Illicit drug use on non-government cheque issue days [ Time Frame: 26 weeks ]Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with individual cheque issue day (among intervention participants), compared to non-cheque issue days.
- Hospital admissions on government cheque issue days [ Time Frame: 26 weeks ]Emergency Department, Emergency Department Mental Health and substance use hospitalizations in the three days beginning with government cheque issue day compared to non-cheque issue days.
- Overdose [ Time Frame: 26 weeks ]Self-reported non-fatal overdose and hospital record verified fatal overdose on the three days beginning with government cheque issue day compared to non-cheque issue days.
- Police service utilization [ Time Frame: 26 weeks ]Self-reported and police record-verified interactions with police or use of police services on the three days beginning with government cheque issue day compared to non-cheque issue days.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 64 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- be ≥19 years of age or older
- reside in greater Vancouver, Canada
- report regular use of illicit drugs other than cannabis
- receive monthly provincial income assistance
- are not currently administered (where cheque issue/money is externally managed)
- be eligible and willing to be a client of the local credit union who will administer the intervention
- report intensified drug use around government cheque issue days
- provide written informed consent
- be willing to comply with study procedures
Exclusion Criteria:
- plan to relocate outside Vancouver
- have plans to discontinue income assistance

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02457949
Canada, British Columbia | |
British Columbia Centre on Substance Use | |
Vancouver, British Columbia, Canada, V6Z 2A9 |
Principal Investigator: | Lindsey Richardson, DPhil | University of British Columbia |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Lindsey Richardson, Assistant Professor, University of British Columbia |
ClinicalTrials.gov Identifier: | NCT02457949 |
Other Study ID Numbers: |
H14-02401 |
First Posted: | May 29, 2015 Key Record Dates |
Last Update Posted: | November 17, 2020 |
Last Verified: | November 2020 |
Social Assistance Drug Use Drug-Related harm |